Here, we hypothesized that these divergent findings occur because APOE ε4 effects on behavior are mediated by subtle, preclinical AD pathology in confined brain regions, which may be compensated by increased recruitment of unaffected areas—possibly resulting in altered cognitive strategies. The gene discussed is APOE; the disease is Alzheimer disease.